Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,108.00
Bid: 1,108.00
Ask: 1,110.00
Change: 8.00 (0.73%)
Spread: 2.00 (0.181%)
Open: 1,128.00
High: 1,128.00
Low: 1,100.00
Prev. Close: 1,100.00
SVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

14 Jan 2021 07:00

RNS Number : 6207L
Savills PLC
14 January 2021
 

 

14 January 2021

SAVILLS PLC

("Savills" or the "Group")

 

Year-End Trading Update

 

 

 

Savills plc, the international real estate advisor, publishes the following trading update in respect of the year ended 31 December 2020.

 

Against the backdrop of the COVID-19 pandemic, the Group has delivered a resilient full year performance reflecting both the robustness and geographic diversity of our business and the mitigating actions taken by staff across the globe. Thanks largely to excellent performances in the UK, Asia Pacific and Savills Investment Management, reflecting the strength of our less transactional service lines, the Group anticipates that underlying results for the year to 31 December 2020 will be at the upper end of the Board's expectations.

 

Covid-19 impact and response

 

Savills has shown considerable resilience in a year in which the Group faced significant challenges, particularly to our transactional advisory businesses worldwide. The cycle of lockdowns and other measures, such as travel restrictions, from Q1 2020 had a significant global impact on the ability and preparedness of both investors and occupiers of real estate to transact. As a consequence, in major markets, both investment and leasing volumes contracted significantly compared with 2019 and previous periods.

 

As announced previously, the Group was quick to adopt a number of operational and financial initiatives to minimise the impact on the business as a whole. Savills strategy was to minimise discretionary expenditure while maintaining our staffing levels to ensure seamless service to clients around the Globe. In addition the Board suspended distributions to shareholders pending greater visibility of future market recovery. The consequence, particularly of retaining our staff, has been improved market share in most of our markets. This both partially mitigated the impact of volume declines in transactional markets and improved our win ratio of tenders for less transactional real estate services such as consultancy and property management. Additional cash management activities, including taking the opportunity in H1, at no cost, to defer certain predominantly VAT/sales tax payments of c. £50m, ensured that the Group remained in a robust financial position through the period and finished the year with net cash in excess of £160m (2019: £28.5m).

 

Performance by region

 

UK

 

Despite the backdrop of restrictions and uncertainty, the UK performed well across all business lines with notably strong performances from our Consultancy and Property Management businesses. Commercial transaction activities, particularly leasing, were significantly affected by the pandemic. Our Commercial investment activities benefited from our involvement in some of the largest transactions seen in the UK and more generally from an increase in activity, albeit still substantially below 2019 levels, which began to occur in Q4. Our UK prime residential business, which effectively missed the spring selling season during the first lockdown, showed an extraordinary rebound in activity from the end of May, predominantly in the regional markets outside London where the volume of activity in prime residential markets for the year as a whole was the strongest since before the global financial crisis.

 

Asia Pacific

 

Our Asia Pacific business as a whole performed ahead of our original expectations as markets such as Mainland China recovered more quickly from the original lockdowns and residential sales activity remained strong through the period. Commercial investment volumes were significantly reduced, however we partially mitigated the impact with market share gains in China including Hong Kong. We also benefited from a strong performance by our substantial Property and Facilities Management business in the region. Korea, Vietnam and Japan also performed well during the period and by the end of the year there was a discernible improvement in sentiment in both Australia and Singapore.

 

Europe & the Middle East

 

In Continental Europe and the Middle East, where our business is much more dependent upon transactional activity, Savills performed broadly in line with expectations in the context of a decline in the transaction volumes in some of the major markets. Those countries where we provide the broadest range of services such as the Middle East, Germany, the Netherlands and Spain showed relative resilience to declines in transactional activity.

 

North America

 

In North America, where Savills is largely focused on commercial occupier leasing transactions, the pandemic, had a significant effect on our business, with market leasing volumes declining by c. 40% year-on-year and more (c.50%-70%) in the largest metro markets of New York, San Francisco, Chicago and Los Angeles. Against that backdrop, market share gains and our ability to close some individually significant transactions partially mitigated the market-related decline in our leasing revenues.

 

SIM

 

Savills Investment Management performed ahead of our expectations with both new fund launches and strong investment performance from the majority of our products. Our strategy was to adopt a cautious approach to the deployment of capital in markets where, for much of the period, there was limited price transparency. Accordingly, whilst base management fees remained highly resilient the business experienced better than anticipated, albeit substantially reduced year-on-year, performance and transaction fees during the period.

 

Outlook

 

Looking to the year ahead, with renewed lockdowns and substantial increases in infection rates in most markets, it is too early to predict the direction of market activity in the short term. That said, global investor demand for secure income, restricted supply and expectations of continued low interest rates suggest that the medium and long term attraction of real estate as an asset class remains highly positive. The pace and efficacy of mass vaccination programmes and consequent reductions in lockdown and travel restrictions will dictate the rate at which transactional markets recover from here to reflect underlying demand. With the operating environment currently restricted in most markets, the Board considers it inappropriate to resume guidance at this stage. However, in general terms, we expect transactional activity to remain suppressed in the first half of 2021 with improvement commencing in some individual markets in the second quarter followed by progressive recovery through the second half of the year.

 

Savills is a resilient, globally diversified business with a strong balance sheet and the Group is well positioned to continue to execute its growth strategies and further enhance its market position.

 

 

Savills intends to report 2020 full year results on 11 March 2021.

 

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

 

Forward looking statements

Certain statements in this announcement are forward-looking statements relating to the Group's operations, performance and financial position based on current expectations of, and assumptions and forecasts made by, management. They are subject to a number of risks, uncertainties and other factors which could cause actual results, performance or achievements of the Group to differ materially from any outcomes or results expressed or implied by such forward-looking statements. The Group's principal risks are described in the 2019 Savills plc Annual Report which can be viewed online at http://www.savills.com. Such forward looking statements should therefore be construed in light of such risks, uncertainties and other factors and undue reliance should not be placed on them. They are made only as of the date of this announcement and no representation, assurance, guarantee or warranty is given in relation to them including as to their accuracy, completeness, or the basis on which they are made. No obligation is accepted to publicly revise or update these forward-looking statements or adjust them as a result of new information or for future events or developments, except to the extent legally required. Nothing in this Statement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVTLAIVLIL
Date   Source Headline
12th Mar 20194:46 pmRNSDirector/PDMR Shareholding
6th Mar 20196:03 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
25th Feb 20199:03 amRNSHolding(s) in Company
15th Feb 20197:00 amRNSBlock listing Interim Review
12th Feb 201912:48 pmRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSTotal Voting Rights
21st Jan 201910:55 amRNSBlock listing Interim Review
15th Jan 20197:00 amRNSTrading Statement
14th Jan 20199:50 amRNSDirector/PDMR Shareholding
2nd Jan 20197:00 amRNSTotal Voting Rights
11th Dec 20183:07 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSTotal Voting Rights
16th Nov 20182:44 pmRNSHolding(s) in Company
13th Nov 20182:46 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTotal Voting Rights
16th Oct 20183:13 pmRNSHolding(s) in Company
11th Oct 20183:26 pmRNSDirector/PDMR Shareholding
2nd Oct 201812:53 pmRNSDirector/PDMR Shareholding
1st Oct 20187:00 amRNSTotal Voting Rights
28th Sep 201812:28 pmRNSAcquisition
19th Sep 20189:34 amRNSDirectorate Change
18th Sep 20189:56 amRNSDirector/PDMR Shareholding
11th Sep 20181:58 pmRNSDirector/PDMR Shareholding
3rd Sep 20183:50 pmRNSTotal Voting Rights
15th Aug 20183:00 pmRNSBlock listing Interim Review
14th Aug 201811:00 amRNSDirector/PDMR Shareholding
13th Aug 201812:41 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSHalf-year Report
1st Aug 20187:00 amRNSTotal Voting Rights
26th Jul 201811:25 amRNSProposed Acquisition of Minority Interest
26th Jul 201811:19 amRNSAcquisition of Minority Interest
23rd Jul 20187:00 amRNSBlock listing Interim Review
16th Jul 201812:23 pmRNSDirector/PDMR Shareholding
15th Jun 20183:35 pmRNSDirector/PDMR Shareholding
14th Jun 201811:53 amRNSDirector/PDMR Shareholding
13th Jun 201812:00 pmRNSIssue of Equity
1st Jun 20187:00 amRNSTotal Voting Rights
14th May 201810:55 amRNSDirector/PDMR Shareholding
8th May 20184:37 pmRNSResult of AGM
8th May 201812:00 pmRNSAGM Statement
1st May 20187:00 amRNSTotal Voting Rights
26th Apr 20182:54 pmRNSDirector/PDMR Shareholding
25th Apr 20181:31 pmRNSDirector/PDMR Shareholding
18th Apr 201812:00 pmRNSIssue of Equity
17th Apr 201810:00 amRNSDirector/PDMR Shareholding
11th Apr 20181:15 pmRNSDirector/PDMR Shareholding
9th Apr 201812:31 pmRNSAnnual Report and AGM Notice
3rd Apr 20187:00 amRNSTotal Voting Rights
22nd Mar 201810:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.